Chilton Investment Company’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.71M Sell
14,196
-880
-6% -$102K 0.04% 137
2025
Q4
$1.59M Buy
15,076
+1,947
+15% +$183K 0.03% 127
2025
Q3
$1.1M Buy
13,129
+5,488
+72% +$452K 0.02% 145
2025
Q2
$605K Buy
7,641
+4,457
+140% +$354K 0.01% 143
2025
Q1
$286K Sell
3,184
-22,563
-88% -$2.11M 0.01% 178
2024
Q4
$2.56M Sell
25,747
-2,275
-8% -$235K 0.07% 84
2024
Q3
$3.18M Sell
28,022
-942
-3% -$112K 0.08% 78
2024
Q2
$3.59M Sell
28,964
-27,070
-48% -$3.49M 0.1% 64
2024
Q1
$7.39M Sell
56,034
-51,080
-48% -$6.3M 0.2% 52
2023
Q4
$11.7M Sell
107,114
-17,121
-14% -$1.78M 0.34% 41
2023
Q3
$12.8M Buy
124,235
+4,587
+4% +$494K 0.41% 38
2023
Q2
$13.8M Buy
119,648
+13,718
+13% +$1.56M 0.4% 36
2023
Q1
$11.3M Buy
105,930
+689
+0.7% +$74.4K 0.35% 38
2022
Q4
$11.7M Sell
105,241
-18,235
-15% -$1.86M 0.36% 34
2022
Q3
$10.6M Sell
123,476
-1,175
-0.9% -$105K 0.33% 32
2022
Q2
$11.4M Buy
124,651
+40,075
+47% +$3.55M 0.32% 33
2022
Q1
$6.94M Buy
84,576
+32,140
+61% +$2.53M 0.17% 42
2021
Q4
$4.02M Buy
52,436
+22,631
+76% +$1.8M 0.08% 60
2021
Q3
$2.24M Buy
29,805
+2,360
+9% +$179K 0.06% 77
2021
Q2
$2.13M Sell
27,445
-111,198
-80% -$8.27M 0.05% 73
2021
Q1
$10.2M Sell
138,643
-42,762
-24% -$3.15M 0.28% 43
2020
Q4
$14.2M Buy
181,405
+78,614
+76% +$6.01M 0.4% 34
2020
Q3
$8.14M Buy
102,791
+22,713
+28% +$1.78M 0.24% 42
2020
Q2
$5.91M Buy
80,078
+54,989
+219% +$4.14M 0.2% 47
2020
Q1
$1.84M Buy
25,089
+16,393
+189% +$1.29M 0.07% 68
2019
Q4
$755K Buy
8,696
+3,889
+81% +$319K 0.02% 90
2019
Q3
$386K Sell
4,807
-5,797
-55% -$465K 0.01% 105
2019
Q2
$848K Sell
10,604
-5,745
-35% -$440K 0.03% 82
2019
Q1
$1.3M Buy
16,349
+3,021
+23% +$226K 0.05% 79
2018
Q4
$972K Buy
13,328
+3,685
+38% +$260K 0.04% 92
2018
Q3
$653K Buy
9,643
+120
+1% +$7.64K 0.02% 103
2018
Q2
$552K Hold
9,523
0.02% 111
2018
Q1
$495K Hold
9,523
0.02% 114
2017
Q4
$511K Sell
9,523
-2,545
-21% -$141K 0.02% 107
2017
Q3
$737K Sell
12,068
-139
-1% -$8.43K 0.03% 102
2017
Q2
$747K Buy
12,207
+1,531
+14% +$93.2K 0.03% 104
2017
Q1
$647K Buy
10,676
+4,506
+73% +$273K 0.03% 103
2016
Q4
$347K Sell
6,170
-1,708
-22% -$100K 0.01% 113
2016
Q3
$469K Sell
7,878
-2,204
-22% -$129K 0.02% 101
2016
Q2
$554K Hold
10,082
0.02% 102
2016
Q1
$509K Sell
10,082
-12,366
-55% -$606K 0.02% 99
2015
Q4
$1.13M Sell
22,448
-1,965
-8% -$99.1K 0.04% 95
2015
Q3
$1.15M Hold
24,413
0.04% 116
2015
Q2
$1.33M Buy
24,413
+8,768
+56% +$492K 0.05% 105
2015
Q1
$858K Buy
15,645
+1,709
+12% +$96.8K 0.03% 117
2014
Q4
$755K Buy
13,936
+4,724
+51% +$263K 0.03% 128
2014
Q3
$521K Buy
+9,212
New +$517K 0.02% 140
2014
Q2
Sell
-9,212
Closed -$499K 146
2014
Q1
$499K Sell
9,212
-131
-1% -$6.78K 0.02% 132
2013
Q4
$446K Sell
9,343
-23,475
-72% -$1.07M 0.01% 137
2013
Q3
$1.49M Sell
32,818
-1,504
-4% -$68.7K 0.04% 117
2013
Q2
$1.52M Buy
+34,322
New +$1.53M 0.04% 116

Other funds holding MRK

Chilton Investment Company's MRK Position: Q1 2026 in Review

Chilton Investment Company reduced its Merck (MRK) stake by 5.8% in Q1 2026, selling an estimated $102K and leaving 14,196 shares worth $1.71M. The position accounts for 0.04% of the portfolio, ranked #137.

Chilton Investment Company first reported a position in MRK in Q2 2013 and has held it in 51 quarters since. The position peaked at $14.2M in Q4 2020. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Chilton Investment Company held 14,196 shares of Merck worth $1.71M as of Q1 2026.
  • Chilton Investment Company sold 880 Merck shares in Q1 2026, an estimated $102K.
  • Merck made up 0.04% of Chilton Investment Company's portfolio in Q1 2026, its #137 holding.
  • Chilton Investment Company first reported a position in Merck in Q2 2013 and has held it in 51 quarters since.
  • Chilton Investment Company's Merck position peaked at $14.2M in Q4 2020.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Chilton Investment Company's 13F filing for Q1 2026, filed 15 May 2026.